Is Seleniso covered by Medicare?

塞利尼索（Selinexor）是一种口服的抗癌药物，属于核蛋白转运抑制剂。 Its main component is selinexor, which interferes with the transport process of nuclear proteins and inhibits the exchange of proteins between the nucleus and cytoplasm, thereby affecting the survival and proliferation of cancer cells.

Seleniso is already on the market in China and has been included in medical insurance, but its price is quite expensive, about 10,000 to 20,000 yuan, making patients bear higher treatment costs. It is recommended to consult the local hospital pharmacy for specific prices and medical insurance reimbursement status.

Different from the domestic market, there are two options for seliniso in the foreign market: original drugs and generic drugs. The original drug is the American version of the original drug. Because of its higher research and development costs, the price is even more expensive, even as high as hundreds of thousands of yuan. In comparison, generic drugs are more affordable. Lao generic drugs are one of the relatively low-priced generic drugs, with prices ranging from 2,000 yuan to 4,000 yuan. Compared with original drugs, they are more affordable. The ingredients of original drugs and generic drugs are basically the same.

The drug's mechanism of action is mainly to bind and inhibit nuclear proteinXPO1 (Exportin 1), which is a key nuclear protein transport protein.通过阻止某些蛋白质进入细胞核，塞利尼索影响细胞的正常功能，尤其是在癌细胞中产生显著的效果。

塞利尼索主要用于治疗多发性骨髓瘤，一种由骨髓中浆细胞异常增生引起的白血病。特别适用于那些对其他治疗方法无效或难以耐受的患者。其在难治性或复发性多发性骨髓瘤的治疗中发挥着重要作用，旨在延长患者的生存期并提高生活质量。